| GU Malignancies - Renal |
|
In October 2006, a multidisciplinary approach to treating high risk GU Malignancies was the focus of a symposium in Monte Carlo, Monaco. It brought together an expert faculty panel of Urologists, Medical Oncologists and Radiation Oncologists for an in-depth discussion on the new opportunities and controversies in treatment. The advent of new pharmaceutical treatments, refined surgical procedures and combination therapies potentially redefine the standard of care and increase survival with quality of life. UroToday.com is pleased to offer the following 5 new state-of-the-art presentations focusing on the latest approaches to high risk and advanced renal cell carcinoma. You can also view the 11 new presentations on high risk and advanced prostate cancer. Renal Cell Carcinoma Partial Nephrectomy: Should This Be The Standard For Stage T1 Renal Cancer? Identifying And Improving Outcomes In The High Risk Patient With Renal Cell Carcinoma Radical Nephrectomy The Role Of Surgery In mRCC Metastatic Renal Cell Carcinoma What’s Hot In The Treatment Of Renal Cell Carcinoma And Is There Hope? Bone Metastases In Renal Cell Carcinoma: What Can Be Done?
Please log-in or register in order to submit comments. Powered by AkoComment! |
||